Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells
Science Immunology · 2024
DOI: 10.1126/sciimmunol.adl2388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von Benjamin Y Winer und 20 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Phagocytosis, Cell Membrane, Mice, Knockout. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Professional phagocytes like neutrophils and macrophages tightly control what they consume, how much they consume, and when they move after cargo uptake. We show that plasma membrane abundance is a key arbiter of these cellular behaviors. Neutrophils and macrophages lacking the G protein subunit Gβ 4 exhibited profound plasma membrane expansion, accompanied by marked reduction in plasma membrane tension. These biophysical changes promoted the phagocytosis of bacteria, fungus, apoptotic corpses, and cancer cells. We also found that Gβ 4 -deficient neutrophils are defective in the normal inhibition of migration following cargo uptake. Sphingolipid synthesis played a central role in these phenotypes by driving plasma membrane accumulation in cells lacking Gβ 4 . In Gβ 4 knockout mice, neutrophils not only exhibited enhanced phagocytosis of inhaled fungal conidia in the lung but also increased trafficking of engulfed pathogens to other organs. Together, these results reveal an unexpected, biophysical control mechanism central to myeloid functional decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
- Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
- Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
- Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Benjamin Y Winer, Alexander H Settle, Tomi Lazarov, Murray Tipping, Anjelique Sawh, Michael Galiano, Justin S A Perry, Frederic Geissmann, Justin Cross, Ting Zhou, Lance C Kam, H Amalia Pasolli, Tobias Hohl, Jason G Cyster, Orion D Weiner, Morgan Huse
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Winer, B. Y., Settle, A. H., Yakimov, A. M., Jeronimo, C., Lazarov, T., Tipping, M., Saoi, M., Sawh, A., Sepp, A. L., Galiano, M., Perry, J. S. A., Wong, Y. Y., Geissmann, F., Cross, J., Zhou, T., Kam, L. C., Pasolli, H. A., Hohl, T., Cyster, J. G., …, & Huse, M. (2024). Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells. Science Immunology. https://doi.org/10.1126/sciimmunol.adl2388
Vancouver
Winer BY, Settle AH, Yakimov AM, Jeronimo C, Lazarov T, Tipping M, et al. Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells. Science Immunology. 2024. doi:10.1126/sciimmunol.adl2388
BibTeX
@article{Winer2024,
author = {Winer, Benjamin Y and Settle, Alexander H and Yakimov, Alexandrina M and Jeronimo, Carlos and Lazarov, Tomi and Tipping, Murray and Saoi, Michelle and Sawh, Anjelique and Sepp, Anna-Liisa L and Galiano, Michael and Perry, Justin S A and Wong, Yung Yu and Geissmann, Frederic and Cross, Justin and Zhou, Ting and Kam, Lance C and Pasolli, H Amalia and Hohl, Tobias and Cyster, Jason G and Weiner, Orion D and Huse, Morgan},
title = {Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cells},
journal = {Science Immunology},
year = {2024},
doi = {10.1126/sciimmunol.adl2388}
}
EUVIMED